Safety and immunogenicity of the tetravalent, live-attenuated dengue vaccine Butantan-DV in adults in Brazil: a two-step, double-blind, randomised placebo-controlled phase 2 trial
Esper G. Kallás, Alexander Roberto Precioso, Ricardo Palácios, Beatriz Thomé, Patricia Emília Braga, Tázio Vanni, Lúcia Maria Arruda Campos, Lílian Pereira Ferrari, Gabriella Mondini, Maria da Graça Salomão, A. R. Da Silva, Heloísa Maximo Espínola, Joane do Prado Santos, Cecília Luiza Simões Santos, María do Carmo Sampaio Tavares Timenetsky, João Luiz Miraglia, Neuza Maria Frazatti Gallina, Daniela Weiskopf, Alessandro Sette, Raphaella Goulart, Rafael Tavares Salles, Alvino Maestri, Adriana Maluf Elias Sallum, Sylvia Costa Lima Farhat, Neusa Keico Sakita, Juliana Caires de Oliveira Achili Ferreira, Cássia Gisele Terrassani Silveira, Priscilla R. Costa, Isaı́as Raw, Stephen S. Whitehead, Anna P. Durbin, Jorge Kalil
Topics & Concepts
MedicinePlaceboSeroconversionImmunogenicityVaccinationDengue vaccineAdverse effectRandomized controlled trialDengue virusInternal medicineDengue feverImmunologyAntibodyAlternative medicinePathologyMosquito-borne diseases and controlVirology and Viral DiseasesViral Infections and Outbreaks Research